Share This Author
Core outcome measures for chronic pain clinical trials: IMMPACT recommendations
Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations.
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
Pharmacologic management of neuropathic pain: Evidence-based recommendations
The prevalence of chronic pain in United States adults: results of an Internet-based survey.
Recommendations for the pharmacological management of neuropathic pain: an overview and literature update.
The objectives of the current article are to review the Neuropathic Pain Special Interest Group guidelines for the pharmacological management of neuropathic pain and to provide a brief overview of several recent clinical trials.
Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations.
Randomized controlled clinical trials of gabapentin, the 5% lidocaine patch, opioid analgesics, tramadol hydrochloride, and tricyclic antidepressants provide an evidence-based approach to the treatment of neuropathic pain.
Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline.
Although the CIPN trials are inconclusive regarding tricyclic antidepressants (such as nortriptyline), gabapentin, and a compounded topical gel containing baclofen, amitriptylines HCL, and ketamine, these agents may be offered on the basis of data supporting their utility in other neuropathic pain conditions given the limited other CIPn treatment options.
Recommendations for the management of herpes zoster.
The results of controlled trials and the clinical experience of the authors support the use of acyclovir, brivudin (where available), famciclovir, and valacy Clovir as first-line antiviral therapy for the treatment of patients with HZ.